3.03
-0.07 (-2.26%)
-0.07 (-2.26%)
Upgrade to Real-Time
Afterhours (Closed)
Low
0.6526
High
8.78
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Moleculin Biotech Inc | MBRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.07 | -2.26% | 3.03 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.11 | 3.01 | 3.21 | 3.05 | 3.10 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.05 | 3.13 | 0.08 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 835 | 236,419 | $ 3.06 | $ 722,328 | - | 0.6526 - 8.78 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:25:04 | 1 | $ 3.11 | USD |
Period:
Draw Mode:
Moleculin Biotech Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 86.51M | 28.55M | 27.98M | $ - | $ - | -1.73 | -1.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 585.08k | 5.30% |
Moleculin Biotech News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MBRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.16 | 3.24 | 3.01 | 3.16 | 154,199 | -0.13 | -4.11% |
| 1 Month | 3.56 | 3.74 | 3.01 | 3.34 | 225,914 | -0.53 | -14.89% |
| 3 Months | 3.36 | 3.99 | 3.01 | 3.57 | 273,186 | -0.33 | -9.82% |
| 6 Months | 4.88 | 5.74 | 3.01 | 4.30 | 1,131,702 | -1.85 | -37.91% |
| 1 Year | 1.10 | 8.78 | 0.6526 | 2.94 | 1,658,569 | 1.93 | 175.45% |
| 3 Years | 1.60 | 8.78 | 0.323 | 1.85 | 1,785,671 | 1.43 | 89.38% |
| 5 Years | 6.96 | 8.78 | 0.323 | 1.92 | 1,390,676 | -3.93 | -56.47% |
Moleculin Biotech Description
| Moleculin Biotech Inc is a clinical-stage pharmaceutical company with its focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next generation anthracycline; Immune/Transcription Modulators, of which WP1066 is a member; and Metabolism/Glycosylation Inhibitors, of which WP1122 is a member. |
